Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Post by mcv1on Oct 29, 2019 12:15am
154 Views
Post# 30279625

Misreading the MD&A???

Misreading the MD&A???There is clearly a disconnect between the October 15th new release stating cash flow positive this quarter and the MD&A talking about onboarding 10,000 new patients by December 31, 2019.

I think people may be misreading the MD&A. I believe in the context of the paragraph the 10,000 patients are new ones since onboarding was restarted. I believe it does not include all the patients from Paz, Rio Grande etc. which is supposed to be 48,000 total patients based on an April 2018 investor presentation. So if you add the 10k +48k patients you get 58k patients. I am assuming $30 per patient since most are at $50/ month from the old Paz & Rio Grande contracts you get: 58,000 patients X $30/ month X 3 months = $5.22 million. Q4 had expenses of $4.75 million. So if expenses don't go up much in Q1 and Q2 then cash flow positive is reasonable to assume.

Just because we don't see the revenue in June 2019 might be because they didn't getting the billing issues sorted out until summer to get paid from Paz and Rio Grande. I don't know if this is case. I may be totally wrong and 10k is the total number of patients. But this makes no sense since there were 12k patients onboarded in April 2018 and I doubt this number went down. I believe it went up and we are just starting to collect revenues from these clients.

Would be useful if someone clarified this point with Lisa. People may be needlessly panicking by misreading the MD&A. Any comments?

Bullboard Posts